Simultaneous Inference of Cancer Pathways and Tumor Progression from Cross-Sectional Mutation Data
Recent cancer sequencing studies provide a wealth of somatic mutation data from a large number of patients. One of the most intriguing and challenging questions arising from this data is to determine whether the temporal order of somatic mutations in a cancer follows any common progression. Since we usually obtain only one sample from a patient, such inferences are commonly made from cross-sectional data from different patients. This analysis is complicated by the extensive variation in the somatic mutations across different patients, variation that is reduced by examining combinations of mutations in various pathways. Thus far, methods to reconstruction tumor progression at the pathway level have restricted attention to known, a priori defined pathways.
In this work we show how to simultaneously infer pathways and the temporal order of their mutations from cross-sectional data, leveraging on the exclusivity property of driver mutations within a pathway. We define the Pathway Linear Progression Model, and derive a combinatorial formulation for the problem of finding the optimal model from mutation data. We show that while this problem is NP-hard, with enough samples its optimal solution uniquely identifies the correct model with high probability even when errors are present in the mutation data. We then formulate the problem as an integer linear program (ILP), which allows the analysis of datasets from recent studies with large number of samples. We use our algorithm to analyze somatic mutation data from three cancer studies, including two studies from The Cancer Genome Atlas (TCGA) on large number of samples on colorectal cancer and glioblastoma. The models reconstructed with our method capture most of the current knowledge of the progression of somatic mutations in these cancer types, while also providing new insights on the tumor progression at the pathway level.
KeywordsBayesian Network Somatic Mutation KRAS Mutation TP53 Mutation Cancer Pathway
Unable to display preview. Download preview PDF.
- 8.Cheng, Y.-K., Beroukhim, R., Levine, R.L., Mellinghoff, I.K., Holland, E.C., et al.: A mathematical methodology for determining the temporal order of pathway alterations arising during gliomagenesis. PLoS Comput. Biol. 8(1), e1002337 (2012)Google Scholar
- 13.Efron, B., Tibshirani, R.: An introduction to the bootstrap, 1st edn. Chapman and Hall (1994)Google Scholar
- 17.Gerstung, M., Eriksson, N., Lin, J., Vogelstein, B., Beerenwinkel, N.: The temporal order of genetic and pathway alterations in tumorigenesis. PLoS One 6(11), e27136 (2011)Google Scholar
- 21.Leiserson, M.D.M., Blokh, D., Sharan, R., Raphael, B.J.: Simultaneous identification of multiple driver pathways in cancer. PLoS Comput. Biol. 9(5), e1003054 (2013)Google Scholar
- 25.Shahrabi Farahani, H., Lagergren, J.: Learning oncogenetic networks by reducing to mixed integer linear programming. PLoS One 8(6), e65773 (2013)Google Scholar
- 26.The Cancer Genome Atlas Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455(7216), 1061–1068 (2008)Google Scholar
- 27.The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487(7407), 330–337 (2012)Google Scholar
- 28.Tofigh, A., Sjölund, E., Höglund, M., Lagergren, J.: A global structural em algorithm for a model of cancer progression. Advances in Neural Information Processing Systems 24, 163–171 (2011)Google Scholar
- 34.Zhang, J., Baran, J., Cros, A., Guberman, J.M., Haider, S., et al.: International Cancer Genome Consortium Data Portal–a one-stop shop for cancer genomics data. Database (2011)Google Scholar